Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? |
May 2020 |
Best practice & research. Clinical haematology |
Myelodysplastic Syndromes (MDS) |
Clonal Hematopoiesis and therapy related MDS/AML |
Mar 2019 |
Best Practice & Research. Clinical Heamatology |
Myelodysplastic Syndromes (MDS) |
Consider Allogeneic Bone Marrow Transplantation for Older, Fit Patients with Aplastic Anemia |
Jan 2019 |
Biol Blood Marrow Transplant |
Aplastic Anemia |
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab. |
Feb 2019 |
Biol Blood Marrow Transplant. |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Hematopoietic Cell Transplantation With Cryopreserved Grafts for Severe Aplastic Anemia |
May 2020 |
Biology of blood and marrow transplantation: journal of the America Society of Blood and Marrow Transplantation |
Aplastic Anemia |
A Case Series of Post-Transplantation Cyclophosphamide in Unrelated Donor Hematopoietic Cell Transplantation for Aplastic Anemia |
Jun 2020 |
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation |
Aplastic Anemia |
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate, but not High Disease Risk Index: A CIBMTR Study: Superior DFS with MAC comp |
Sep 2020 |
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia |
Dec 2020 |
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation |
Aplastic Anemia |
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes |
Aug 2020 |
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation |
Myelodysplastic Syndromes (MDS) |
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes |
Nov 2020 |
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation |
Myelodysplastic Syndromes (MDS) |